Category: Pharmaceuticals
Pharmaceuticals market research reports by IMARC Services Pvt. Ltd.
-
Gastrointestinal OTC Drugs Market by Drug Class (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), Indication (Gastroesophageal Reflux Disease (GERD) or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2025-2033
The global gastrointestinal OTC drugs market size reached USD 43.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.82% during 2025-2033. The rising prevalence of gastrointestinal disorders, increasing awareness ... Read More
-
Male External Catheters Market by Type (Disposable External Catheters, Reusable External Catheters), Application (Hospitals, Home Care, and Others), and Region 2025-2033
The global male external catheters market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.33% during 2025-2033. The growing geriatric population across the globe, continual advancements in me ... Read More
-
Oral Antibiotics Market Report by Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, and Others), Application (Community-acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental and Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic, Narrow Spectrum Antibiotic), Drug Type (Branded, Generics), and Region 2025-2033
The global oral antibiotics market size reached USD 21,078.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 27,949.3 Million by 2033, exhibiting a growth rate (CAGR) of 3.18% during 2025-2033. The increasing prevalence of infectious diseases, expanding geriatric popula ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the gro ... Read More
-
Skin Lightening Products Market Report by Product (Creams, Cleanser, Mask, and Others), Nature (Synthetic, Natural, Organic), Gender (Men, Women), Distribution Channel (Hypermarkets and Supermarkets, Specialty Stores, Pharma and Drug Stores, Online Sales Channel, and Others), and Region 2025-2033
The global skin lightening products market size reached USD 11.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 19.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. The growing demand for organic skin lightening products among the masses, incre ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2025-2033
The global non-alcoholic steatohepatitis (NASH) market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.5 Billion by 2033, exhibiting a growth rate (CAGR) of 22.97% during 2025-2033. The rising prevalence of NASH, increasing awareness regarding ea ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
The global anti-tuberculosis therapeutics market size reached USD 1,530.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,552.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The rising healthcare spending, favorable reimbursement policies ... Read More
-
Albumin Market Report by Product (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), Application (Therapeutics, Drug Formulation and Vaccine, Component of Media, and Others), End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Research Institutes), and Region 2025-2033
The global albumin market size reached USD 6.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is primarily driven by increasing demand for biopharmaceuticals, rising prevalence o ... Read More
-
Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033
The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
The global systemic lupus erythematosus (SLE) drugs market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.54% during 2025-2033. The increasing number of patients suffering from SLE, rising p ... Read More
-
Osteosynthesis Devices Market by Type (Internal, External), Material (Non-Degradable, Degradable), Fracture Type (Patella, Tibia or Fibula or Ankle, Clavicle, Scapula or Humerus, Radius or Ulna, Hand, Wrist, Vertebral Column, Pelvis, Hip, Femur, Foot Bones, and Others), End User (Hospitals, Orthopedic Specialist Clinics, and Others), and Region 2025-2033
The global osteosynthesis devices market size reached USD 10.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.67% during 2025-2033. The increasing incidences of road accidents across the globe and the rising pr ... Read More
-
Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2025-2033
The global vaccine vials market size reached USD 695.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,465.1 Million by 2033, exhibiting a growth rate (CAGR) of 8.63% during 2025-2033. The increasing prevalence of infectious diseases, significant technological innovat ... Read More
-
Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2025-2033
The global respiratory diagnostics market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The growing prevalence of respiratory diseases, rising healthcare expenditure, ... Read More
-
Bioactive Materials Market by Material (Glass, Glass-ceramics, Composite, and Others), Type (Powder, Moldable, Granules, and Others), Application (Dentistry, Surgery, Bioengineering, and Others), and Region 2025-2033
The global bioactive materials market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.86% during 2025-2033. The escalating demand for regenerative medicine is stimulating the market. Bioacti ... Read More
-
Equine Healthcare Market by Product (Drugs, Vaccines, Medicated Feed Additives, Diagnostics, and Others), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, and Others), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores), and Region 2025-2033
The global equine healthcare market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.31% during 2025-2033. The rapid increase in the equine population, rising awareness among owners regarding ... Read More
-
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033
The global biopreservation market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.98% during 2025-2033. The growing focus on personalized medicine among the masses, the increasing investment ... Read More
-
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033
The global hepatitis diagnostic tests market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033. The market is experiencing robust growth, driven by the rising prevalence of ... Read More
-
Cataract Surgical Devices Market Report by Product Type (Ophthalmic viscoelastic devices (OVDs), Intraocular lenses (IOLs), Femtosecond laser, Phacoemulsification equipment, and Others), End-Use (Hospitals, Eye care clinics, Eye Treatment and Surgical Centres), and Region 2025-2033
The global cataract surgical devices market size reached USD 9.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.8 Billion by 2033, exhibiting a growth rate (CAGR) of 3.48% during 2025-2033. The growing number of cataract cases, the introduction of sophisticated devi ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2025-2033
The global hormone replacement therapy market size reached USD 9.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.27% during 2025-2033. The rising prevalence of hormonal disorders, increased awareness and accep ... Read More
-
Pea Protein Market Report by Product Type (Isolates, Concentrates, Textured), Application (Dietary Supplements, Bakery Products, Meat Substitutes, Beverages, and Others), End User (Retail, Institutional), and Region 2025-2033
The global pea protein market size reached USD 1,237.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,183.7 Million by 2033, exhibiting a growth rate (CAGR) of 12.54% during 2025-2033. The rising consumer consciousness about the importance of maintaining a nutritious ... Read More
-
Healthcare Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033
The global healthcare packaging market size reached USD 154.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 257.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The rising healthcare expenditure, growing aging population, stringent regulat ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
The global RNA interference (RNAi) drug delivery market size reached USD 99.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 466.1 Billion by 2033, exhibiting a growth rate (CAGR) of 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to ... Read More
-
Anti-Aging Market Report by Demography (Age Group, Gender, Income), Industry (Skin Care Industry, Hair Care Industry, Dental Care Industry), Product Type (Anti-Wrinkle Products, Anti-Pigmentation Products, Sunscreen Products, Hair Care Products), Devices and Technology (Microdermabrasion Devices, Aesthetic Energy Devices), and Country 2025-2033
The global anti-aging market size reached USD 75.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 122.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The burgeoning demand for anti-aging solutions among the geriatric population, continuous ... Read More
-
GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033
The GCC generic drug market size reached USD 6.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2033, exhibiting a growth rate (CAGR) of 10.04% during 2025-2033. Generic drugs are bioequivalent of branded medicines, which have similar dosages, risks, ef ... Read More
-
Bioactive Ingredients Market Report by Ingredients Type (Fibers, Vitamins, Omega-3 PUFA, Minerals, Carotenoids and Antioxidants, Probiotics, Plant Extracts, and Others), Application (Dietary Supplements, Functional Beverages, Personal Care, Animal Nutrition), and Region 2025-2033
The global bioactive ingredients market size reached USD 52.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 91.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.14% during 2025-2033. The growing consumer health consciousness, along with the extensive product app ... Read More
Research Assistance
